Juha Näpänkangas

Further Insight into Mechanism of Action of Clodronate: Inhibition of Mitochondrial ADP/ATP Translocase by a Nonhydrolyzable, Adenine-Containing Metabolite

Petri Lehenkari, Maarit Kellinsalmi, Juha Näpänkangas et al. · Molecular Pharmacology · 2002 · 327 citations

Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma

Tiina Kantola, Kai Klintrup, Juha P. Väyrynen et al. · British Journal of Cancer · 2012 · 237 citations · Full text

Tumor Biology, Oncology, Medicine +7

MicroRNA-125b and chemokine CCL4 expression are associated with calcific aortic valve disease

Pauli Ohukainen, Suvi Syväranta, Juha Näpänkangas et al. · Annals of Medicine · 2015 · 79 citations · Full text

Activation of nuclear receptor PXR impairs glucose tolerance and dysregulates GLUT2 expression and subcellular localization in liver

Fatemeh Hassani‐Nezhad‐Gashti, Jaana Rysä, Outi Kummu et al. · Biochemical Pharmacology · 2018 · 52 citations · Full text

Nuclear Receptor Pxr, Metabolic Syndrome, Insulin Signaling +13

(Pro)renin Receptor Triggers Distinct Angiotensin II-Independent Extracellular Matrix Remodeling and Deterioration of Cardiac Function

Anne‐Mari Moilanen, Jaana Rysä, Raisa Serpi et al. · PLoS ONE · 2012 · 44 citations · Full text